… Ireland Alexion, AstraZeneca Rare Disease today … and Sustainability, Alexion, AstraZeneca Rare Disease. Pic: … and Sustainability, Alexion, AstraZeneca Rare Disease, commented: “ … CEO of IDA Ireland, added: “I would like to congratulate Alexion, AstraZeneca …

… States. Confirming the move, an AstraZeneca spokesperson said, “We constantly reassess … -European Union exit. In February, Chief Executive Pascal Soriot described the Merseyside … ’s administration has reportedly accelerated AstraZeneca’s drive to strengthen a …

… the alliance, joining AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, GSK … members," said Leeland Ekstrom, chief executive officer of NashBio. "Additional …

… each of the drug manufacturers’ chief executive officers (CEOs), stated that “Most proposals … in the letter to the CEOs and some additional details surrounding … received the letter: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb …

… Maltzahn, the company's chief executive and a former Flagship partner … Series B – led by the AstraZeneca-CICC healthcare investment fund – that …

… time, Eli Lilly's chief executive, David Ricks, stated that post … Last week, British pharmaceutical titan Astrazeneca put a halt to a …

… at the time, Eli Lilly chief executive David Ricks said the UK … Last week, British drug giant Astrazeneca paused a planned £200m expansion …

… successive UK governments.” FTSE darling Astrazeneca also paused its £200m Cambridge … earlier this year. Richard Torbett, chief executive of Association of the British … next five years, while competitor Astrazeneca promised a “landmark investment” of …

… Campus, the Wellcome Genome Campus, AstraZeneca, Cambridge Innovation Capital, One Nucleus … the three days.” Robert Evans, chief executive, Wellcome Genome Campus, said: “We …

… company's chair and chief executive officer, Dave Ricks, announced that … 's pharmaceutical front, as AstraZeneca announced earlier this year it … the city was not on AstraZeneca's short list of …